PATHOLOGICAL-CHANGES IN THE LONG-TERM TRANSPLANTED HEART - A MORPHOMETRIC STUDY OF MYOCARDIAL HYPERTROPHY, VASCULARITY, AND FIBROSIS

被引:48
|
作者
ROWAN, RA
BILLINGHAM, ME
机构
[1] Department of Pathology, Stanford University School of Medicine, Stanford, CA
关键词
endomyocardial biopsies; light and electron microscopic morphometry;
D O I
10.1016/0046-8177(90)90037-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Myocyte hypertrophy and myocardial fibrosis have been observed in transplanted human hearts, and both could potentially have an adverse effect on long-term cardiac function. There has been some concern that distant donor heart procurement and cyclosporine treatment increase the risk of these changes, but their incidence and severity have not been documented quantitatively in large numbers of cardiac transplant recipients. We used light microscopic morphometric methods to estimate myocardial collagen volume fraction and myocyte width in right ventricular endomyocardial biopsies from 95 recipients at 3 years posttransplantation, and electron microscopic stereology to estimate myocardial vascularity and myocyte myofibril content in 40 recipients, also at 3 years posttransplantation. We compared those with locally and distantly procured donor hearts (mean ischemic time 160 minutes) and cyclosporine versus noncyclosporine immunosuppression. Controls were pretransplant right ventricular biopsies from 20 donor hearts which were free of heart disease. We found no significant differences in myocardial collagen volume fractions. Myocyte hypertrophy was typical of all the transplant biopsies (mean myocyte width 20.2 μm, SD 3.0 in all transplants versus 11.8 μm, SD 2.2 in controls, P < 0.001), but distant donor procurement and cyclosporine had no significant effect. There were significant reductions of myofibril volume fraction in the transplants, which raises the possibility of gradual decompensation in some patients. There were no significant differences in myocardial vascularity, although a few patients were well below the control range. We conclude that distant donor heart procurement, with ischemic times averaging less than 3 hours, and cyclosporine treatment are not responsible for significant hypertrophy or fibrosis in most transplants. Hypertrophy is typical of the transplanted heart, and it is possible that associated abnormalities might have an effect on cardiac function in some long-term survivors. © 1990.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 50 条
  • [21] Long-Term Prognostic Value of Myocardial Fibrosis in Chagas' Disease
    Senra, Tiago
    Ianni, Barbara
    Mady, Charles
    Martinelli, Martino
    Filho, Roberto Kalil
    Rochitte, Carlos E.
    CIRCULATION, 2016, 134
  • [22] Silent Myocardial Infarction and Long-Term Risk of Heart Failure The ARIC Study
    Qureshi, Waqas T.
    Zhang, Zhu-Ming
    Chang, Patricia P.
    Rosamond, Wayne D.
    Kitzman, Dalane W.
    Wagenknecht, Lynne E.
    Soliman, Elsayed Z.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (01) : 1 - 8
  • [23] MORPHOMETRIC CHANGES OF LUNG FOLLOWING LONG-TERM INTERMITTENT OZONE EXPOSURE
    BOORMAN, GA
    SCHWARTZ, LW
    TYLER, NK
    BRUMMER, MEG
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1978, 117 (04): : 220 - 220
  • [24] CHANGES IN HEART SIZE DURING LONG-TERM TIMOLOL TREATMENT AFTER MYOCARDIAL-INFARCTION
    GUNDERSEN, T
    TRAETTEBERG, K
    RONNEVIK, P
    VONBRANDIS, C
    BARSTAD, S
    ABRAHAMSEN, AM
    ACTA MEDICA SCANDINAVICA, 1984, 215 (01): : 33 - 41
  • [25] Long-term changes in left ventricular hypertrophy after renal transplantation
    Rigatto, C
    Foley, RN
    Kent, GM
    Guttmann, R
    Parfrey, PS
    TRANSPLANTATION, 2000, 70 (04) : 570 - 575
  • [26] Long-term effect of vasectomy on spermatogenesis in men: a morphometric study
    Xiang, Yu
    Luo, Peng
    Cao, Yun
    Yang, Zheng-Wei
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (03) : 434 - 436
  • [27] Optimising long-term preservation of the transplanted heart using glyceryl trinitrate and cariporide
    Hing, A.
    Hicks, M.
    Gao, L.
    Faddy, S. C.
    McMabon, A. C.
    Kesteven, S. H.
    Feneley, T. P.
    Wilson, F. K.
    Macdonald, P. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S160 - S160
  • [28] REGRESSION OF MYOCARDIAL HYPERTROPHY IN HYPERTENSIVES ON LONG-TERM TREATMENT WITH BETA-BLOCKERS
    FRANZ, IW
    WIEWEL, D
    BEHR, M
    KETELHUT, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (14) : 530 - 534
  • [29] Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy
    Suckau, Lennart
    Fechner, Henry
    Chemaly, Elie
    Krohn, Stefanie
    Hadri, Lahouaria
    Kockskaemper, Jens
    Westermann, Dirk
    Bisping, Egbert
    Ly, Hung
    Wang, Xiaomin
    Kawase, Yoshiaki
    Chen, Jiqiu
    Liang, Lifan
    Sipo, Isaac
    Vetter, Roland
    Weger, Stefan
    Kurreck, Jens
    Erdmann, Volker
    Tschope, Carsten
    Pieske, Burkert
    Lebeche, Djamel
    Schultheiss, Heinz-Peter
    Hajjar, Roger J.
    Poller, Wolfgang C.
    CIRCULATION, 2009, 119 (09) : 1241 - 1252
  • [30] CAPILLARY GROWTH AND GEOMETRY DURING LONG-TERM HYPERTENSION AND MYOCARDIAL HYPERTROPHY IN DOGS
    TOMANEK, RJ
    WESSEL, TJ
    HARRISON, DG
    AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04): : H1011 - H1018